General AML

Naval Daver | ASH 2018 | Key highlights of immunotherapeutic agents for AML at ASH 2018

L:

Naval Daver from the MD Anderson Cancer Center, Houston, US, provided updates on data presented at the 2018 American Society of Hematology meeting, on immunotherapeutic agents for acute myeloid leukemia. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!
0% of people found this article informative